dr. brufsky discusses bevacizumab benefits in tnbc
Published 12 years ago • 231 plays • Length 0:35Download video MP4
Download video MP3
Similar videos
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:22
dr. brufsky on cobimetinib plus paclitaxel in tnbc
-
4:12
assessing the use of bevacizumab
-
1:45
dr. sikov on bevacizumab or carboplatin impact on tnbc subtype
-
1:31
dr. brufsky discusses the tnacity trial
-
1:06
dr. brufsky on challenges in breast cancer
-
1:46
dr. brufsky discusses adjuvant bisphosphonates as a new standard of care
-
0:39
dr. brufsky discusses future research into bisphosphonates
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:57
dr. tripathy discusses the averel bevacizumab trial results
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:36
dr. rugo on the efficacy of bevacizumab in breast cancer
-
1:49
cobimetinib plus paclitaxel in tnbc
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:06
dr. jason konner discusses bevacizumab in ovarian cancer
-
4:35
role of neoadjuvant platinum-based therapy for tnbc
-
5:49
immunotherapy for tnbc